CM
CLVS

Corvex Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Corvex Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-93,586
Closed -$4.25M – 51
2014
Q3 		$4.25M Buy
+93,586
New +$3.91M 0.05% 42

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Corvex Management's CLVS Position: Q4 2014 in Review

Corvex Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2014, closing a stake of 93,586 shares — an estimated $4.25M sold.

Corvex Management first reported a position in CLVS in Q3 2014 and held it in 1 quarter. The position peaked at $4.25M in Q3 2014. 143 funds tracked by Wall St. Rank hold CLVS as of Q4 2014.

  • Corvex Management reported no remaining Clovis Oncology, Inc. position as of Q4 2014 after selling out during the quarter.
  • Corvex Management sold 93,586 Clovis Oncology, Inc. shares in Q4 2014, an estimated $4.25M.
  • Corvex Management first reported a position in Clovis Oncology, Inc. in Q3 2014 and held it in 1 quarter.
  • Corvex Management's Clovis Oncology, Inc. position peaked at $4.25M in Q3 2014.
  • 143 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2014.

Based on Corvex Management's 13F filing for Q4 2014, filed 17 Feb 2015.